Several reports have suggested the presence of a adrenergic receptors in the rat seminal vesicle (1, 2). Adeneken (3) has reported evidence for a,-adrenergic receptor predominance in the rat seminal vesicle. A previ ous study (4) demonstrated that rat seminal vesicle mem branes contained a, and j3-adrenergic receptors regulated inversely by androgens.
In rat ventral prostate membrane preparations, /3 adrenergic agonists stimulated adenylate cyclase activity with the observed properties characteristic of a (32-subtype receptor (5-7). As for al-adrenergic receptors, it has become increasingly clear that there are at least two pharmacologically distinct subtypes of al-adrenergic receptors: alA-subtypes that are not inactivated by the site-directed alkylating agent chlorethylclonidine (CEC) and a,B-subpopulations that are sensitive to . In the present study, I investigated the properties of a and /3-adrenergic receptors of rat seminal vesicle mem branes and the regulation of adrenergic receptors by gua nine nucleotides and muscarinic cholinergic agonists.
MATERIALS AND METHODS
Seminal vesicles from male Wistar rats weighing 300 to 350 g (Nippon Rats Co., Ltd.) were homogenized in 20 mM Tris-HCl buffer, pH 7.4, containing 0.25 mM su crose, 4 mM MgC12, 1 mM EDTA and 3.25 mM 2-mer captoethanol by a Potter-Elvehjen homogenizer. The homogenate was centrifuged at 600 x g for 10 min. The su pernatant was centrifuged at 20,000 x g for 20 min. Crude membrane preparations were incubated for 20 min with or without 100 pM CEC and washed three times. The membrane preparations were assayed for /3-adrenergic receptor binding with 3H-dihydroalprenolol (3H-DHA, 52.3 Ci/mmol; New England Nuclear, Boston, MA, USA), as previously described (12-15). Membranes (0.2-0.3 mg of protein) were incubated with 3H-DHA (1-20 nM) in a buffer (40 mM Tris-HCI, pH 7.4, 10 mM MgC12) for 10 min at 371C. The a, and a2-adrenergic receptor binding study was performed with 3H-prazosin (0.1 5.0 nM, 30 Ci/mmol, New England Nuclear, Boston, MA, USA) or 3H-clonidine (0.5 5.0 nM, 28.3 Ci/mmol, New England Nuclear, Boston, MA, USA), respectively. Incubations of the membranes (0.1 0.2 mg of protein) with 3H-prazosin or 3H-clonidine in 40 mM Tris-HCl buffer, pH 7.4, containing 10 mM MgC12, 1 mM sodium l-ascorbate and 1 mM pyrocatechol were carried out for 30 min at 371C, as previously described (4, 16, 17) . For the experiments of CEC pretreatment, incubations of the membranes with or without 100 pM CEC for 20 min were followed by wash ing with the medium, 3 times, before the binding assay. Incubations for the binding assay were terminated by a rapid dilution of the assay mixture, followed by filtration through Whatman GF/B glass fiber filters. Specific bind ing to receptors, defined as the difference between the radioactivity bound in the presence or absence of 20 ,uM propranolol, 10 pM phentolamine or 5 pM clonidine, was approximately 65 to 75% of the total binding. The concen trations of protein were measured by the method of Lowry et al. (18) .
The drugs used were: l-propranolol (Japan ICI Phar ma), phentolamine (Japan Ciba Geigy), 1-isoproterenol (Nikken Chemicals), salbutamol (Sankyo Pharmaceuti cal), I-epinephrine (Dainippon Seiyaku), norepinephrine (Wako Chemicals), carbachol (Sigma Chemical), chlor ethylclonidine (CEC, Research Biochemicals), atropine (Sigma Chemical Co.), 2-2,6-dimethoxy-phenoxyethyl aminomethyl-1,4-benzodioxane (WB4101, Amersham) and dihydroergocryptine (DHE, Sandoz). 
RESULTS
The saturable and specific binding of 3H-DHA to semi nal vesicle membranes was demonstrated by the linearity of the Scatchard analysis, indicating a single class of receptors, and the number of binding sites was calculated to be 93.8 ± 1.8 fmol/mg protein with an apparent affin ity, Kd, of 6.3±0.3 nM (Fig. 1) . The agonists competed for the receptor binding sites in the following order of potency:
l-isoproterenol > epinephrine > salbutamol > 1 norepinephrine; graphical estimation of the concentra tion resulting in half maximal inhibition gave IC50 values for isoproterenol, epinephrine, salbutamol and nor epinephrine of 0.01, 0.61, 0.82, and 2.10 pM, respectively (Fig. 2) . Affinity of the (3-adrenergic receptor for isopro terenol was decreased by the guanine nucleotide (GTP, 50 pM), as demonstrated by an increase of more than one order of magnitude in the IC50 value for isoproterenol in the presence of GTP (Fig. 3) . Addition of the cholinergic agonist carbachol (10 pM) had no effect on the decreased affinity of the (3-adrenergic receptor for isoproterenol by the guanine nucleotide (Fig. 3) .
The binding of 3H-prazosin, a,-adrenergic antagonist, to seminal vesicle membranes was also to a single, satu rable population of sites, with a linear Scatchard plot, and the number of binding sites was 46.8±0.3 fmol/mg protein with a high affinity Kd of 0.36±0.01 nM (Fig. 4) . Pretreatments with 100 pM CEC for 20 min caused no significant decrease in the density of specific 3H-prazosin binding sites in seminal vesicle membranes (Fig. 5) . Guanine nucleotide (GTP, 100 ,uM) significantly de creased the affinity of al-adrenergic receptors for epi nephrine, causing an increase of more than one order of magnitude in the IC50 value for epinephrine in the presence of GTP (Fig. 7) . The GTP-induced reduction in the affinity of a,-adrenergic receptors for epinephrine was significantly reversed by addition of carbachol (10 riM) (Fig. 7) . Carbachol had no effect on the specific 3H-prazo sin binding either alone or in the presence of GTP (data not shown). Atropine, an antagonist for muscarinic cholinergic agonists, effectively reversed the effects of car bachol on the competitive inhibition of 3H-prazosin bind ing by epinephrine in the presence of GTP (Fig. 7) . No sig nificant binding sites for 3H-clonidine were observed (data not shown). 
DISCUSSION
The observed order of potency for agonist in compet ing for the (3-adrenergic binding sites was 1-isoproter enol > epinephrine salbutamol > 1-norepinephrine, indi cating that these receptors have properties characteristic of a typical (32-adrenergic receptor system. Guanine nucleotides have been reported to modulate receptor bind ing function (19) (20) (21) (22) . Membranes from seminal vesicles responded to GTP with decreased ~-adrenergic receptor ligand affinity. Carbachol, a muscarinic cholinergic agonist, had no effect on the GTP regulation. Membranes from the rat seminal vesicle showed saturable and high affinity binding sites for the a,-adrenergic receptor an tagonist, confirming the previous study (4). No specific binding for the a2-adrenergic receptor agonist 3H-cloni dine was observed (data not shown), indicating a predominance of a,-adrenergic receptors in the rat semi nal vesicle (3). Guanine nucleotides have been demonstrat ed to decrease the affinity of a, and a2-adrenergic recep tors for epinephrine (23, 24) . The effect of GTP on decreasing the affinity of the a,-adrenergic receptor bind 277-278 (1989) 
